Cleared Traditional

K151839 - AMC Health VitalCaregiving System

K151839 is an FDA 510(k) clearance for AMC Health VitalCaregiving System, manufactured by Amc Health. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 431-day FDA review.

K151839 · Amc Health · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2016
Decision
431d
Days
Class 2
Risk

K151839 is an FDA 510(k) clearance for the AMC Health VitalCaregiving System. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Amc Health (New York, US). The FDA issued a Cleared decision on September 9, 2016 after a review of 431 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Amc Health devices

FDA 510(k) Submission Details - K151839

510(k) Number K151839 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 2015
Decision Date September 09, 2016
Days to Decision 431 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
306d slower than avg
Panel avg: 125d · This submission: 431d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 296
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K151839.
Truscope Ultra Patient Monitor
K162234 · Guangdong Biolight Meditech Co., Ltd. · Jan 2017
IQvitals Zone
K161909 · Midmark Corporation · Nov 2016
Vital Sync Informatics Manager & Virtual Patient Monitoring Platform
K160718 · Covidien · Nov 2016
LD-Oxi system
K160956 · Ld Technology, LLC · Jul 2016
MRI Patient Monitor TeslaDUO
K153739 · Mipm Mammendorfer Institut Fur Physik Und Medizin · Jun 2016
Masimo Root Monitoring System and Accessories
K153225 · Masimo Corporation · Jun 2016